Point 3.6 of Annex II to Regulation (EC) No 1107/2009 refers to the assessment of the impact of active substances, safeners and synergists on human health. As regards active substances that are micro-organisms, currently available scientific knowledge includes knowledge regarding the assessment of pathogenicity of micro-organisms to humans, infectivity of viruses and the capacity of bacteria to transfer anti-microbial resistance genes to other micro-organisms, potentially affecting the effectiveness of antimicrobials used in human or veterinary medicine. This scientific knowledge shows that further specification is needed regarding the approval criteria laid down in Article 4 of Regulation (EC) No 1107/2009, implementing the most up-to-date scientific and technical knowledge in the risk assessment of micro-organisms. It is therefore appropriate to specify the approval criteria applying for micro-organisms.
Recital 9, Regulation (EU) 2022/1438
In forcesince 31 Aug 2022